Cognetix

Neurosciences

This company develops precision sodium channel therapeutics to treat patients with neurological conditions such as genetic epilepsy and chronic neuropathic pain.

EpilepsyGTx

This company develops precision gene therapies for patients with focal refractory epilepsy to provide seizure freedom.

Cognito Tx

This company develops non-invasive wearable devices using light and sound stimulation to treat patients with Alzheimer's and other neurodegenerative diseases.

Sentonix

This company develops small-molecule drugs to treat neurodegenerative disorders for patients with unmet medical needs.

Axonis

This biotechnology company develops oral small molecule therapies targeting the KCC2 protein to treat patients with epilepsy, chronic pain and spinal cord injuries.

Focalis

Focalis Bio develops gene therapies delivering engineered potassium channels to treat patients suffering from focal refractory epilepsy.

CeNeRx

This biopharmaceutical company develops clinical-stage therapeutics for central nervous system disorders, such as depression and pain, for patients and healthcare providers.

Cognition Therapeutics

This company develops oral small-molecule medications for patients with neurodegenerative disorders such as Alzheimer's disease and dementia with Lewy bodies.